display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
locally advanced NSCLC - (neo)adjuvant (NA)metastatic/advanced NSCLC (mNSCLC) - 1st line (L1)NSCLC neoadjuvant setting
locally advanced NSCLC - (neo)adjuvant (NA)mNSCLC - L1 - PDL1 negativeNSCLC neoadjuvant setting
nivolumab plus SoC CheckMate 816 CheckMate 227 ... CheckMate 816

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons